Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways

导出原文传递

翻译打印收藏纠错

作者： Shin,D.-Y. ^[1] ; Chung,J. ^[2] ; Joe,Y. ^[3] ; Pae,H.-O. ^[4] ; Chang,K.C. ^[5] ; Cho,G.J. ^[6] ; Ryter,S.W. ; Chung,H.-T.

作者单位： School of Biological Sciences, University of Ulsan, Ulsan 680-749, South Korea, World Class ^[1] Department of Anatomy, Institute of Health Sciences, Gyeongsang National University, Jinju, South ^[2] Department of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical ^[3] Department of Microbiology and Immunology, Wonkwang University School of Medicine, Iksan, South ^[4] School of Biological Sciences, University of Ulsan, Ulsan 680-749, South Korea ^[5] Department of Pharmacology, Institute of Health Sciences, Gyeongsang National University, Jinju ^[6]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood

2012年119卷11期

2523-2532页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways

Blood

相似文献

Blood

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways

Blood

相似文献

Blood

相关期刊

检索历史清除